HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Ovary Removal Cuts Breast Cancer Mortality Risk

By HospiMedica International staff writers
Posted on 06 May 2015
Print article
Women with BRCA-positive breast cancer had a significantly lower risk of dying after prophylactic bilateral oophorectomy, according to a new study.

Researchers at McGill University (Montreal, Canada), the Women’s College Research Institute (WCRI; Toronto, ON, Canada), and another 12 institutions conducted a retrospective study of 676 women with stage I or II breast cancer and a BRCA1 or BRCA2 mutation, followed for up to 20 years (after receiving a diagnosis between 1975 and 2008) to estimate the impact of oophorectomy on survival. Survival experience was compared for women who did and who did not undergo oophorectomy, with the primary endpoint being death due to breast cancer.

In all, out of the 676 women, 345 underwent oophorectomy after the diagnosis of breast cancer, while 331 retained both ovaries. The results showed that the magnitude of benefit for ovary removal was 43% for carriers of BRCA2 carriers, and 62% for carriers of BRCA1. Risk reduction jumped to 93% for estrogen receptor-negative breast cancers, which account for a majority of BRCA1-positive breast cancers. The study was published early online on April 23, 2015, in JAMA Oncology.

“In this study, we confirm that women with breast cancer and a BRCA1 mutation improve their prognosis if they undergo oophorectomy, and that the protective effect of the oophorectomy persists beyond age 50 years,” said lead author Steven Narod, MD, of WCRI, and colleagues. “In previous studies, we have shown that oophorectomy reduces the risk of both ovarian and breast cancers, and we now report that the benefits of oophorectomy include a reduction in the risk of breast cancer mortality.”

The risk of developing breast and ovarian cancer is greatly increased if a woman inherits a mutation in the BRCA1 or BRCA2 gene, which produces tumor suppressor proteins. Together, BRCA1 and BRCA2 mutations account for about 20%–25% percent of hereditary breast cancers, and about 5%–10% of all breast cancers. Several study groups have recommended prophylactic salpingo-oophorectomy for BRCA carriers at age 35 or older to reduce the risk of breast and ovarian cancer.

Related Links:

McGill University
Women’s College Research Institute



Gold Member
12-Channel ECG
CM1200B
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Computerized Spirometer
DatospirAira

Print article

Channels

Critical Care

view channel
Image: The new risk assessment tool determines patient-specific risks of developing unfavorable outcomes with heart failure (Photo courtesy of 123RF)

Powerful AI Risk Assessment Tool Predicts Outcomes in Heart Failure Patients

Heart failure is a serious condition where the heart cannot pump sufficient blood to meet the body's needs, leading to symptoms like fatigue, weakness, and swelling in the legs and feet, and it can ultimately... Read more

Surgical Techniques

view channel
Image: The multi-sensing device can be implanted into blood vessels to help physicians deliver timely treatment (Photo courtesy of IIT)

Miniaturized Implantable Multi-Sensors Device to Monitor Vessels Health

Researchers have embarked on a project to develop a multi-sensing device that can be implanted into blood vessels like peripheral veins or arteries to monitor a range of bodily parameters and overall health status.... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more